Vaxcyte
Price & Volume
Stats
See more52W Range | $28.09-$65 |
Market Cap | $8.8B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$75M |
Diluted EPS | -$5.63 |
News
See moreYahoo Finance • 20 days ago
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
Yahoo Finance • 22 days ago
Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Yahoo Finance • 23 days ago
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
Yahoo Finance • 23 days ago
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know
About
CEO | Mr. Grant E. Pickering M.B.A. |
CFO | Mr. Andrew L. Guggenhime M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 507 |
